Synapse - The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS

The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS Meeting Abstract

Authors:	Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; Ponce, D. M.; Sauter, C. S.; van den Brink, M. R. M.; Young, J. W.; O'Reilly, R. J.; Giralt, S.; Goldberg, J. D.; Perales, M. A.
Abstract Title:	The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
Meeting Title:	55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	122
Issue:	21
Meeting Dates:	2013 Dec 7-10
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2013-11-15
Language:	English
ACCESSION:	WOS:000331385004232
PROVIDER:	wos
DOI:	10.1182/blood.V122.21.2045.2045
Notes:	Meeting Abstract: 2045 -- Source: Wos